2. Complications of diabetes mellitus
I. Acute complications:
diabetic ketoacidosis
hypoglycemia
diabetic nonketotic hyperosmolar coma
II. Chronic complications:
a. Microvascular
retinopathy
nephropathy
neuropathy
diabetic foot
dermopathy
b. Macrovascular
Cerbrovascular.
Cardiovascular.
peripheral vascular disease.
DR. RAHUL GARG
3. Diabetic ketoacidosis (DKA)
May be the 1st presentation of type 1 DM.
Result from absolute insulin deficiency or increase
requirement.
Mortality rate around 5%.
DR. RAHUL GARG
4. Pathogenesis
Insulin decrease ↓
Counter-regulatory hormone increase: Glucagon,
catecholamines, cortisol & growth hormone ↑
Hepatic glucose production increase ↑
↓glucose utilization of peripheral tissue
=> glycosuria, osmotic diuresis & dehydra-tion
lead to the release of free fatty acid into circulation
from fatty tissue.
Unrestrained hepatic fatty acid oxidation to ketone
bodies (β-hydroxybutyrate, acetone, acetoacetate)
=> resulting in ketonemia and metabolic acidosis.
DR. RAHUL GARG
7. Clinical presentation of DKA
Polyuria and polydipsia.
Nausea and vomiting.
Anorexia and abdominal pain.
Tachycardia.
Fruity odor of the breath.
Hypotonia, stupor and coma.
Sign of dehydration.
DR. RAHUL GARG
8. Treatment of DKA
Fluid replacement.
Insulin therapy for hyperglycemia.
Electrolyte correction.
Acidosis correction.
Treatment of precipitating cause.
DR. RAHUL GARG
9. Complication of DKA
Cerebral edema
Vascular thrombosis
Infection
M I
Acute gastric dilatation
Respiratory distress syndrome
DR. RAHUL GARG
10. Hypoglycemic coma
Hypoglycemia is the most frequent acute
complication in diabetes.
Hypoglycemia is the level of blood glucose at
which autonomic and neurological dysfunction
begins
DR. RAHUL GARG
14. Treatment of hypoglycemia
In mild cases oral rapidly absorbed carbohydrate
In sever cases (comatose patient) iv hypertonic
glucose 25% or 50% concentration
Glucagons injection
DR. RAHUL GARG
15. Chronic Complications of DM
A. Macrovascular Complications:
B. Microvascular Complications:
DR. RAHUL GARG
16. Macro-vascular Complications:
Ischemic heart diseases.
Cerebrovascular diseases.
Peripheral vascular diseases.
Diabetic patients have a 2 to 6 times higher risk
for development of these complications than the
general population
DR. RAHUL GARG
17. Macro-vascular Complications:
Accelerated atherosclerosis involving the aorta and large- and
medium-sized arteries.
Myocardial infarction, caused by atherosclerosis of the
coronary arteries, is the most common cause of death in
diabetics.
Gangrene of the lower extremities.
Hypertension due to Hyaline arteriolosclerosis.
DR. RAHUL GARG
18. Hypertension in DM
Type 2
Type 1
present after several years of
DM
affects about 30% of patients.
Secondary to
nephropathy
Activation of the Renin
angiotensin system
DR. RAHUL GARG
Mostly present at diagnosis
Affects about 60% of patients
Secondary to insulin resistance
Activation of the sympathetic
nervous system
19. Dyslipidaemia in DM
Most common abnormality is ↓ HDL and ↑
Triglycerides
A low HDL is the most constant predictor of
Cardiovascular disease in DM.
DR. RAHUL GARG
21. Microvascular Complications
Microvascular complications are specific to diabetes and
related to longstanding hyperglycaemia.
Both Type1 DM and Type2 DM are susceptible to
microvascular complications.
The duration of diabetes and the quality of diabetic control
are important determinants of microvascular abnormalities.
DR. RAHUL GARG
22. Pathophysiology of microvascular disease
In diabetes, the microvasculature shows both functional
and structural abnormalities.
The structural hallmark of diabetic
microangiopathy is
thickening of the capillary basement membrane.
changes in basement membrane composition including
increased type IV collagen and its glycosylation (i.e
binding of glucose to wall of blood vessels).
DR. RAHUL GARG
23. The main functional abnormalities include increased
capillary permeability, viscosity, and disturbed platelet
function.
These changes occur early in the course of diabetes
and precede organ failure by many years.
Increased capillary permeability is manifested in the
retina by leakage of fluorescein and in the kidney by
increased urinary losses of albumin which predict
eventual renal failure.
DR. RAHUL GARG
24. Platelets from diabetic patients show an exaggerated tendency to
aggregate, perhaps mediated by altered prostaglandin metabolism.
Plasma and whole blood viscosity are increased in diabetes.
These defects together with the platelet abnormalities may cause stasis
in the microvaculature, leading to increased intravascular pressure and
to tissue hypoxia.
There is abnormal production of von Willebrand factor and endothelial
derived nitric oxide by endothelial cells which could contribute to tissue
damage.
DR. RAHUL GARG
25. 1- Diabetic retinopathy
* Pathogenesis:
Histologically
the earliest lesion is thickening of the capillary basement
membrane.
On
fluorescein angiography the first abnormality is the capillary
dilatations (microaneurysms).
Microaneurysm may give rise to haemorrhage or exudate.
Vascular
occlusion, initially of capillaries and later of arteries and veins,
leads to large ischaemic areas (cotton-wool spots).
DR. RAHUL GARG
34. 2- Diabetic Nephropathy (DN)
- Diabetic nephropathy is defined by persistent
albuminuria (>300 mg/day), decrease glomerular
filtration rate and rising blood pressure.
- About 20 – 30% of patients with diabetes develop
diabetic nephropathy
DR. RAHUL GARG
35. Risk factors of DN
Duration of DM.
Family History of hypertension. Cardiovascular
disease, nephropathy.
Hyperglycemia.
Hypertension.
Microalbuminuria.
Male gender.
Cigarette smoking.
DR. RAHUL GARG
36. Pathogenesis:
The glomerular and vascular lesions are linked to
hyperglycemia.
Nonenzymatic glycosylation to glomerular proteins
results in accumulation of irreversible advanced
glycosylation end products in the glomerular mesangium
and glomerular basement membrane.
This alteration leads to proteinuria and eventually
glomerulosclerosis
DR. RAHUL GARG
37. Pathological pattern of DN
Diffuse form (more common): consist of thickining
of glomerular basement membrane with generalized
mesangial thickenings.
The nodular form (the Kimmelstiel-Wilson
lesion): (accumulation of periodic acid schiff positive
material are deposit in the periphery of glomerular tufts.
DR. RAHUL GARG
38. Diabetic nephropathy
• The glomerulus shows sclerotic nodules in the center of the lobules
or segments.
DR. RAHUL GARG
40. Stages of DN
Stage I
↑ glomerular filtration and kidney hypertrophy
Stage II
u-albumin excretion < 30mg/24h
Stage III
Microalbuminuria (30 – 300 mg/24h)
Stage IV
Overt nephropathy (> 300mg/24h, positive u dipstick)
Stage V
ESRD characterized by ↑ blood urea and creatinine levels,
hyperkalaemia and fluid overload
DR. RAHUL GARG
41. Treatment to prevent progression to DN
Glycaemic control.
ACE inhibitor .
Blood pressure control.
Smoking cessation.
Proteins restriction.
Lipid reduction.
DR. RAHUL GARG
47. Entrapment Neuropathies
Carpal tunnel syndrome (median nerve)
Ulnar compression syndrome
Meralgia paresthetica (lat cut nerve to the thigh)
Lat Popliteal nerve compression (drop foot)
All the above are more common in diabetic patients
DR. RAHUL GARG
51. foot care
Patient should
check feet daily
Wash feet daily
Keep toe nails short
Protect feet
Always wear shoes
Look inside shoes before
putting them on
Always wear socks
Break in new shoes gradually
DR. RAHUL GARG
54. Screening for Neuropathy
128 Hz tuning fork for
testing of vibration
perception
10g Semmers
monofilament
The main reason is to
identify patients at risk
for development of
diabetic foot
DR. RAHUL GARG
Stage I:This stage is usually not clinically evident
Stage II:Renal lesions are found on biopsy
Stage III:Without intervention the average increase in albuminuria in patients with type 1 DM is 20% per year. Blood pressure usually starts to increase once fixed albuminuria exist
Stages I – III are reversible
Stage 3:Overt diabetic nephropathy
After 15 – 25 years in 35% of diabetic patients
Pronounced abnormalities of the glomeruli
GFR decline by 10 ml/min/year
Progressive clinical proteinuria
BP increase by 5 mmHg per year
Nor reversible but progression can be slowed by good glucose control and use of ACE inhibitor
Stage 4:ESRD
Final outcome after 25-30 years
Glomerular closure
GFR < 10 ml/min
Invariably hypertensive
Irreversible
Stage I:This stage is usually not clinically evident
Stage II:Renal lesions are found on biopsy
Stage III:Without intervention the average increase in albuminuria in patients with type 1 DM is 20% per year. Blood pressure usually starts to increase once fixed albuminuria exist
Stages I – III are reversible
Thoracoabdominal radiculopathy. Truncal radiculopathies are rare but can present at the initial diagnosis of diabetes.2 Nerve roots T8 through T12 are commonly affected. Patients complain of a tight bandlike or constricting pain in the chest or abdomen. The chest or abdominal wall skin becomes sensitive to the touch.2 Motor involvement may lead to abdominal muscle weakness, which may lead to herniation and an asymmetric bulge in the abdominal wall.3 Examination of spinal fluid may show an increase of protein.4 Prognosis is generally good; most patients recover within several months.
Sudomotor Dysautonomia
Patients often complain of hyperhidrosis or anhidrosis of the extremities, venous congestion, pain and redness of the feet, and gustatory sweating.5 Gustatory sweating is common in patients with cervical sympathetic denervation, demonstrated by profuse sweating of the face, neck, and upper trunk while eating.12
PMN leukocyte function is depressed, particularly when acidosis is also present. Leukocyte adherence, chemotaxis, and phagocytosis may be affected. Antioxidant systems involved in bactericidal activity may also be impaired.
A standardized filament is pressed against part of the foot. When the filament bends, its tip is exerting a pressure of 10 grams (therefore this monofilament is often referred to as the 10gram monofilament). If the patient cannot feel the monofilament at certain specified sites on the foot, he/she has lost enough sensation to be at risk of developing a neuropathic ulcer. The monofilament has the advantage of being cheaper than a biothesiometer, but to get results which can be compared to others, the monofilament needs to be calibrated to make sure it is exerting a force of 10 grams